-
1
Measurement of Cardiac-Specific Biomarkers in the Emergency Department: New Insight in Risk Evaluation
Published 2023-11-01Subjects: Get full text
Article -
2
Molecular Autopsy of Sudden Cardiac Death in the Genomics Era
Published 2021-07-01“…It is particularly useful in cases where traditional autopsy is negative or only shows non-diagnostic features, i.e., in sudden unexplained deaths (SUDs), which are often due to an underlying inherited arrhythmogenic cardiac disease. The final goal of molecular autopsy in SUD cases is to aid medico-legal inquiries and to guide cascade genetic screening of the victim’s relatives. …”
Get full text
Article -
3
Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond
Published 2022-04-01“…There is some evidence that PFD has antifibrotic actions in various animal models of cardiac disease and a phase II trial on patients with heart failure and preserved ejection fraction has yielded positive results. …”
Get full text
Article -
4
Pathophysiological Rationale and Clinical Evidence for Neurohormonal Modulation in Heart Failure with Preserved Ejection Fraction
Published 2023-06-01“…Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome resulting from the interaction between cardiac diseases, comorbidities and ageing. HFpEF is characterised by the activation of neurohormonal axes, namely of the renin-angiotensin-aldosterone system and the sympathetic nervous system, although to a lesser extent compared with heart failure with reduced ejection fraction. …”
Get full text
Article